Flufenamic acid
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
2-{[3-(Trifluoromethyl)phenyl]amino}benzoic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | Prescription Only (S4) (AU) |
Routes | oral, topical |
Pharmacokinetic data | |
Protein binding | extensively |
Metabolism | Hydroxylation, glucuronidation |
Half-life | ~3 h |
Excretion | 50% urine, 36% feces |
Identifiers | |
CAS number | 530-78-9 |
ATC code | M01AG03 |
PubChem | CID 3371 |
IUPHAR ligand | 2447 |
DrugBank | DB02266 |
ChemSpider | 3254 |
UNII | 60GCX7Y6BH |
KEGG | D01581 |
ChEBI | CHEBI:42638 |
ChEMBL | CHEMBL23588 |
Chemical data | |
Formula | C14H10F3NO2 |
Mol. mass | 281.22991 g/mol |
SMILES
| |
| |
Physical data | |
Melt. point | 124–125 °C (255–257 °F) resolidification and remelting at 134°C to 136°C |
Solubility in water | Practically insoluble in water; soluble in ethanol, chloroform and diethyl ether mg/mL (20 °C) |
(what is this?) (verify) | |
Flufenamic acid, also known as Fluffy or Fluf[citation needed], is a non-steroidal anti-inflammatory drug.[1] It is pale yellow crystalline powder.
Flufenamic acid also blocks voltage-gated sodium channels responsible for the depolarising after-potential (DAP) that underlies phasic firing in the phasic firing of magnocellular neurons in the supraoptic and paraventricular nuclei.[citation needed]
References
- ↑ Lovering, A. L.; Ride, J. P.; Bunce, C. M.; Desmond, J. C.; Cummings, S. M.; White, S. A. (2004). "Crystal structures of prostaglandin D(2) 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin". Cancer research 64 (5): 1802–1810. PMID 14996743.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.